Related Experiment Video

Updated: Sep 25, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Status of research funded by the American Diabetes Association--year 4

Mayer B Davidson

    Diabetes
    |May 27, 2003
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Isolation of Adipose Tissue Immune Cells07:09

    Isolation of Adipose Tissue Immune Cells

    Published on: May 22, 2013

    Isolated Pancreatic Islet Treatment and Apoptosis Measurement09:36

    Isolated Pancreatic Islet Treatment and Apoptosis Measurement

    Published on: May 2, 2025

    Related Concept Videos

    Dipeptidyl Peptidase 4 Inhibitors01:23

    Dipeptidyl Peptidase 4 Inhibitors

    Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...